The ALPHA phase 1 study: pulmonary ArteriaL hypertension treated with CardiosPHere-Derived allogeneic stem cells

By sjmartinez • December 14, 2023

Lewis MI, Shapiro S, Oudiz RJ, Nakamura M, Geft D, Matusov Y, Hage A, Tapson VF, Henry TD, Azizad P, Saggar R, Mirocha J, Karpov OA, Van Eyk JE, Marbán E. The ALPHA phase 1 study: pulmonary ArteriaL hypertension treated with CardiosPHere-Derived allogeneic stem cells. EBioMedicine. 2023 Dec 7:104900. doi: 10.1016/j.ebiom.2023.104900. Epub ahead of print. PMID: 38092579.

Tags: Cardiology/Epi, Harbor UCLA, Progenitor cell therapy, Publications, pulmonary arterial hypertension, Regenerative medicine, right ventricle, Short- and long-term safety

Artificial intelligence prediction of age from echocardiography as a marker for cardiovascular disease

Rawlani M, Ieki H, Binder C, Yuan V, Chiu IM, Bhatt A, Ebinger JE, Sahashi Y, Ambrosy AP, Usuku H, Tsujita K, Cheng P, Kwan[...]

Evaluating oral selexipag in PAH: Insights on survival, safety and dosing patterns from the complete observation period of GRIPHON and its open-label extension

McLaughlin VV, Howard L, Elwing J, Fernandes CC, Gaine S, Galiè N, Oudiz RJ, Stefani M, Stickel S, Strachan P, Tamura Y, Kim NH. Evaluating[...]

Decontrasted Image Registration Improves Quantification of Extracellular Volume and Fractional Myocardial Blood Volume

Lu M, Mahmoudi M, Nguyen KL, Xie Y. Decontrasted Image Registration Improves Quantification of Extracellular Volume and Fractional Myocardial Blood Volume. NMR Biomed. 2025 Dec;38(12):e70179.[...]